| Heyer Celestial Paul Devarapalli Md Sc | |
|
1015 S Evergreen Ave Arlington Heights IL 60005-3144 | |
| (847) 296-0336 | |
| (847) 789-8548 |
| Full Name | Heyer Celestial Paul Devarapalli Md Sc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1015 S Evergreen Ave, Arlington Heights, Illinois |
| Authorized Official Name and Position | Heyer Cp Devarapalli (MEDICAL DIRECTOR) |
| Authorized Official Contact | 8472960336 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Heyer Celestial Paul Devarapalli Md Sc 1015 S Evergreen Ave Arlington Heights IL 60005-3144 Ph: (847) 296-0336 | Heyer Celestial Paul Devarapalli Md Sc 1015 S Evergreen Ave Arlington Heights IL 60005-3144 Ph: (847) 296-0336 |
| NPI Number | 1235327677 |
|---|---|
| Provider Enumeration Date | 10/11/2007 |
| Last Update Date | 01/06/2023 |
| Medicare PECOS PAC ID | 6608963186 |
|---|---|
| Medicare Enrollment ID | O20071031000036 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
Researchers of the University of Bern have identified a new antibiotic resistance gene in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus.
KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.
Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in patients with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance can be safely delayed or avoided in these patients. Full findings are published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235327677 | NPI | - | NPPES |
| 1637966 | Other | IL | BC BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036117190 (Illinois) | Primary |
| Provider Name | Heyer Cp Devarapalli |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588704381 PECOS PAC ID: 5991892549 Enrollment ID: I20071030000466 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
Researchers of the University of Bern have identified a new antibiotic resistance gene in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus.
KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.
Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in patients with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance can be safely delayed or avoided in these patients. Full findings are published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
› Verified 4 days ago
News Archive
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
Researchers of the University of Bern have identified a new antibiotic resistance gene in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus.
KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.
Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in patients with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance can be safely delayed or avoided in these patients. Full findings are published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
› Verified 4 days ago
Shine Functional Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3233 N Arlington Heights Rd, Suite 302, Arlington Heights, IL 60004 Phone: 224-345-2532 | |
The Metabolism, Weight, & Lifestyle Institute, Ltd. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 637 S Bristol Ln, Arlington Heights, IL 60005 Phone: 847-394-0846 Fax: 847-394-9255 | |
Center For Family And Geriatric Medicine, S.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2010 S Arlington Heights Rd, Suite #225, Arlington Heights, IL 60005 Phone: 847-439-2200 Fax: 847-439-8687 | |
Adult Care Specialists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1538 N Arlington Heights Road, Arlington Heights, IL 60004 Phone: 847-253-6464 Fax: 847-253-6501 | |
Pediatric Health Care Associates, S.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1640 N Arlington Heights Rd, Suite 101, Arlington Heights, IL 60004 Phone: 847-577-8272 Fax: 847-577-2149 | |
Solomon Sidea Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1655 N Arlington Heights Rd, Suite 203e, Arlington Heights, IL 60004 Phone: 847-590-1500 Fax: 847-590-1502 | |
Verne A. Schwager, M.d., S.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1009 S Evergreen Ave, Arlington Heights, IL 60005 Phone: 847-392-5580 Fax: 847-392-5155 |